Department of Internal Medicine, Clinica Nefrologica Dialisi e Trapianto, Genoa University and IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Clinica delle Malattie Cardiovascolari, Genoa University and IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Kidney Blood Press Res. 2019;44(4):715-726. doi: 10.1159/000501316. Epub 2019 Aug 20.
Chronic kidney disease (CKD) reduces both Klotho expression and its shedding into circulation, an effect that accelerates progression and cardiovascular complications. However, the mechanisms that regulate Klotho release by the human kidney are still unknown.
We measured plasma Klotho across the kidney, splanchnic organs and lung in 22 patients (71 ± 2 years, estimated glomerular filtration rate [eGFR] 60 ± 5.4 mL/min 1.73 m2) during elective diagnostic cardiac catheterizations.
Although the Klotho average renal vein concentrations were remarkably higher (by ∼9%) than arterial values, the kidney removed Klotho (or was at zero balance) in 7 subjects, indicating that the kidney contribution to systemic Klotho is not constant. Klotho fractional enrichment across the kidney was inversely related to plasma sodium (r = 0.43, p = 0.045) and acid uric acid levels (r = 0.38, p = 0.084) and directly, to renal oxygen extraction (r = 0.56, p = 0.006). In multivariate analysis, renal oxygen extraction was the only predictor of the enrichment of Klotho across the kidney, suggesting the dependence of renal Klotho release on tubular hypoxia or oxidative metabolism. Klotho balance was neutral across the lung. In patients with eGFR <60 mL/min, Klotho was also removed by splanchnic organs (single pass fractional extraction ∼11%).
The present study identifies kidney oxygen uptake as a predictor of Klotho release, and splanchnic organs as a site for Klotho removal. This study provides new understanding of kidney Klotho release and suggests that modulating kidney oxygen metabolism could increase Klotho delivery, as an option to slow disease progression and blunt organ damage.
慢性肾脏病(CKD)降低 Klotho 的表达及其向循环中的释放,这种作用加速了疾病进展和心血管并发症。然而,调节人肾脏 Klotho 释放的机制仍不清楚。
我们在 22 名患者(71±2 岁,估算肾小球滤过率[eGFR]60±5.4mL/min·1.73m2)进行选择性诊断性心导管检查期间,测量了肾脏、内脏器官和肺脏中的血浆 Klotho 浓度。
尽管 Klotho 的平均肾静脉浓度比动脉值高约 9%,但在 7 名患者中肾脏清除了 Klotho(或处于零平衡状态),这表明肾脏对系统 Klotho 的贡献不是恒定的。Klotho 在肾脏中的分数富集与血浆钠(r=0.43,p=0.045)和尿酸水平(r=0.38,p=0.084)呈负相关,与肾脏氧摄取呈正相关(r=0.56,p=0.006)。在多变量分析中,肾脏氧摄取是 Klotho 在肾脏中富集的唯一预测因子,表明肾脏 Klotho 释放依赖于肾小管缺氧或氧化代谢。Klotho 在肺脏中的平衡是中性的。在 eGFR<60mL/min 的患者中,内脏器官也会清除 Klotho(单次通过的分数提取约为 11%)。
本研究确定了肾脏氧摄取作为 Klotho 释放的预测因子,内脏器官作为 Klotho 清除的部位。本研究提供了对肾脏 Klotho 释放的新认识,并表明调节肾脏氧代谢可以增加 Klotho 的输送,作为减缓疾病进展和减轻器官损伤的一种选择。